Read more

March 03, 2022
1 min read
Save

Top in hem/onc: Researchers pause CAR-T trial, no link between meat and colon cancer

Memorial Sloan Kettering Cancer Center paused a phase 1 trial for a chimeric antigen receptor T-cell therapy to investigate the death of a patient who received the treatment. It was the top story in hematology/oncology last week.

The second top story was about a new study published in JAMA Network Open that found the intake of unprocessed red or processed meat was not associated with an increased risk for colon cancer recurrence or death. Researchers said that more studies are needed to identify and confirm associations between dietary factors and cancer survivorship.

Image of red meat in store
Source: Adobe Stock

Read these and more top stories in hematology/oncology below:

Memorial Sloan Kettering pauses CAR-T clinical trial to investigate patient death

Memorial Sloan Kettering Cancer Center placed a pause on a phase 1 clinical trial of ATA2271 — a chimeric antigen receptor T-cell therapy — after one patient treated with the investigational therapy died. Read more.

Unprocessed red meat, processed meat intake not linked to colon cancer recurrence, death

Consumption of unprocessed red or processed meat did not impact risk for colon cancer recurrence or mortality, according to a prospective cohort study of patients with stage III colon cancer published in JAMA Network Open. Read more.

Women express confusion, concern about ductal carcinoma in situ diagnosis, treatment

Women with a history of ductal carcinoma in situ reported confusion and concern about diagnosis and treatment of the noninvasive breast condition, according to results of a national web-based survey published in Cancer. Read more.

Maintaining bond with patients crucial after cancer-directed treatments are no longer beneficial

It’s the news no patient with cancer wants to hear: There’s nothing more we can do for you. Healio spoke with oncologists and palliative care physicians about ways to approach conversations with patients after curative treatments have ceased to be beneficial. Read more.

Insomnia in cancer survivors: A common, potentially harmful issue

Insomnia is an all too familiar modern problem and can negatively impact various aspects of health. Along with other vulnerable populations, patients affected by cancer are particularly susceptible to insomnia. Read more.